EUSA Pharma appoints chief executive and director
April 22, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bryan Morton, Eusa Pharma, Göran Ando, Lee Morley
Recently-established UK-based EUSA Pharma has confirmed the appointment of Lee Morley as its chief executive and Dr Göran Ando (pictured) …
Teva moves to buy Mylan
April 21, 2015Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger
Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …
Merck KGaA and Pfizer alliance begins lung cancer study
April 21, 2015Research and Development, Sales and Marketing Merck KGaA, Pfizer, avelumab, keytruda, oncology, opdivo
Merck KGaA and Pfizer have enrolled and treated the first patient in a late-stage study of their anti-PD1 cancer immunotherapy …
Daiichi Sankyo to sell Sun Pharma stake
April 21, 2015Manufacturing and Production, Sales and Marketing Daiichi Sankyo, FDA, India, Ranbaxy, Sun Pharma, generics
Daiichi Sankyo is to sell off all or part of its stake in Sun Pharma and back away from the …
Novartis MS drug scores positive late-stage trial result
April 21, 2015Research and Development, Sales and Marketing MS, Novartis, fingolimod, gilenya, multiple sclerosis
People with some of the most common forms of multiple sclerosis (MS) who are treated with Gilenya are less likely …
UK firm unveils respiratory apps
April 21, 2015Medical Communications, Sales and Marketing Activ8rlives, Aseptika, SENSOR, communications, digital
Cambridgeshire-based healthcare tech firm Aseptika has made its suite of apps available to support studies in respiratory research. The UK …
Four join the ranks of IDEA Pharma
April 21, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anastasia Liapis, Cindy Peché, IDEA Pharma, Louise Ward, Vivian Huang
IDEA Pharma has made four new appointments in Louise Ward as project manager and Cindy Peché as head of group …
Sanofi sues decision aid maker for ‘injurious falsehood’
April 20, 2015Medical Communications, Sales and Marketing Diagnosia, Sanofi, metamizole, tech
A tech start-up says it is being sued by pharma giant Sanofi for presenting facts about a drug’s side effects …
Merck seeks new Keytruda indication in US
April 20, 2015Sales and Marketing Cancer, FDA, NSCLC, PD-L1, US, keytruda, lung, pembrolizumab
Merck is seeking FDA approval for its successful melanoma drug Keytruda to be used treating lung cancer. The Supplemental Biologics …
Round one to Pfizer in Zoloft lawsuit battle
April 20, 2015Sales and Marketing Pfizer, Zoloft, antidepressant, birth defects, law suits, legal, sertraline
Pfizer’s Zoloft did not cause a young boy’s birth defects, a jury has ruled, in the first of a thousand …
AstraZeneca lung drug shows promise
April 20, 2015Sales and Marketing AZ, AZD9291, AstraZeneca, European Lung Cancer Congress, NSCLC, Orphan
AstraZeneca’s non-small cell lung cancer offering AZD9291 has been shown to delay disease progression by over a year. Data presented …
What you need to know about the EU Clinical Trial Regulation
April 20, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EU Clinical Trial Regulation, EU-CTR, Virginia Acha
Where did the EU Clinical Trial Regulation come from? The EU Clinical Trial Regulation (EU-CTR) was approved in April 2014 …
Celgene appoints former Cubist chief executive
April 20, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, cubist, michael bonney
Celgene has elected pharma veteran Michael Bonney to join its board of directors. Bonney served as chief executive and board …
GSK sees further US job losses following Novartis deal
April 17, 2015Research and Development, Sales and Marketing GSK, Jobs, Novartis, cuts, merger, pittsburgh, restructuring
Hundreds more jobs are at risk within GlaxoSmithKline as the fallout from the company’s asset-swapping deal with Novartis continues. Staff …
AstraZeneca bags another FDA orphan status in cancer
April 17, 2015Sales and Marketing AstraZeneca, Cancer, FDA, GlaxoSmithKline, mekinist, melanoma, oncology, selumetinib, trametinib
The FDA has granted AstraZeneca’s cancer medicine selumetinib orphan drug designation for the treatment of uveal melanoma. The company will …
FDA approves generic Copaxone for multiple sclerosis
April 17, 2015Sales and Marketing FDA, Sandoz, Teva, glatiramer acetate injection, glatopa
The FDA has signed-off on the first generic version of Copaxone to treat people with relapsing forms of multiple sclerosis …
Merck chief executive replaces Pfizer boss as PhRMA chairman
April 17, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing George Scangos, Ian Read, Joaquin Duato, Kenneth Frazier, PhRMA
Chairman and chief executive of Merck Kenneth Frazier is to replace Pfizer boss Ian Read as chairman at the Pharmaceutical …
Merck Serono gains head of global clinical development
April 17, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alise Reicin, Merck, Merck Serono
Merck Serono, the biopharma business of Merck, has appointed Dr Alise Reicin as senior vice president and head of its …
AstraZeneca signs immuno-oncology deal with UK firm
April 16, 2015Research and Development, Sales and Marketing AstraZeneca, IMCgp100, MEDI4736, MedImmune, Oxford, immuno-oncology, immunocore, melanoma, tremelimumab
UK pharma and biotech firms AstraZeneca and Immunocore are teaming up to launch early-stage studies of potential new cancer treatments. …
FDA approves Amgen’s heart failure drug
April 16, 2015Sales and Marketing Amgen, Corlanor, FDA, NICE, Vectibix, heart, ivabradine
Amgen has earned sign-off from the FDA for Corlanor as a treatment for people with worsening heart failure symptoms. Corlanor …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
